• Call Us +972 (0)4 - 828 8500
  • Email Carmel@univ.haifa.ac.il

ResCure Pharma Ltd.

Preventing Breast Cancer Recurrence

Scientific Founders : Dr. Dalit Barkan Dr. Amiram Ariel

Developing novel therapies for the prevention and treatment of recurrent metastatic breast cancer.

Company Background
ResCure Ltd. was founded in 2015 by Carmel - the University of Haifa’s economic corporation. The company is developing novel platform technology for discovery and development of therapies for breast cancer recurrence.

The company’s research is led by Dr. Dalit Barkan and Dr. Amiram Ariel from the University of Haifa. ResCure is in the process of initial validation of potential compounds discovered by the company for the prevention and treatment of metastatic breast cancer recurrence.

Learn more about the technology and research status [hyperlink to technology page]

Incidence of Breast cancer and Drug Market Potential
According to the American Cancer Society:
• In 2017 over 250,000 new cases of invasive breast cancer will be diagnosed in women and over 2,400 in men;
• Approximately 40,000 women and 440 men died of breast cancer in 2015;
• There are over 3.1 million women living with a history of breast cancer.
Approximately 20% of breast cancer patients are at risk of breast cancer recurrence 5-20 years after initial treatment. Recurrence can occur locally (in the treated breast or near the mastectomy scar) or appear as a metastatic disease in distant organs. To date there is no treatment to eradicate metastatic disease. Therefore, it is essential to develop new therapeutic approaches to confront metastatic disease before it emerges.
ResCure is developing a novel approach to preventing and treating metastatic recurrence of breast cancer.

 

Market Assessment
According to a 2015 Global Business Intelligence report, the global breast cancer therapeutics market was valued at $10.4 billion in 2014, and is expected to reach $17.2 billion by 2021, at a compound annual growth rate (CAGR) of 7.3%.

 

IP Status
Patent pending

Innovation Investment & Partnership Opportunities
ResCure Pharma Ltd. received seed investment from the Carmel Innovations Fund, supporting the company’s research and development and steering it towards its present accomplishments.

Related Pages:

 


Carmel Ltd. is now seeking potential partners and/or investors to drive strong company growth and drug market disruption.

Contact us for further information.